Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 41.13
-0.59 (-1.41%)
Sep 12, 2025, 3:00 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 23.50 billion as of September 12, 2025. Its market cap has increased by 0.73% in one year.
Market Cap
23.50B
Enterprise Value
20.24B
Revenue
4.32B
Ranking
n/a
PE Ratio
20.56
Stock Price
41.13
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 23.50B, an increase of 166.47%. That is a compound annual growth rate of 11.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 23.50B | -5.87% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | 65.47B | 61.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 459.54B |
| WuXi AppTec | 307.21B |
| Shenzhen Mindray Bio-Medical Electronics | 291.45B |
| Sichuan Biokin Pharmaceutical | 140.27B |
| Shanghai United Imaging Healthcare | 123.91B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.62B |
| Aier Eye Hospital Group | 119.82B |
| Yunnan Baiyao Group Co.,Ltd | 105.25B |